Publication & Citation Trends
Most Cited Works
Publications
130 total
AZD4512: A novel CD22-directed antibody-drug conjugate for the treatment of b-cell malignancies
Cited by 0
Semantic Scholar
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo OA
Cited by 10
Semantic Scholar
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma OA
Cited by 5
Semantic Scholar
A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression PDF
Cited by 29
OpenAlex
Abstract 2947: Preclinical evaluation of a novel B7-H4 targeted antibody-drug conjugate AZD8205 as a single agent and in combination with novel PARP inhibitor and checkpoint blockade
Cited by 0
Semantic Scholar
A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression. OA
Cited by 19
Semantic Scholar
Abstract 6553: The development of homologous recombination repair deficiency (HRD) score methodology using WES data and its application in patient-derived xenograft models
Cited by 0
Semantic Scholar
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors. OA
Cited by 20
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(43)
Radiopharmaceutical Chemistry and Applications
(38)
Peptidase Inhibition and Analysis
(27)
Monoclonal and Polyclonal Antibodies Research
(22)
Cancer Research and Treatments
(21)
Frequent Co-Authors
Affiliations
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health
AstraZeneca (Netherlands)
AstraZeneca (Japan)
Altimmune (United States)